Literature DB >> 7932916

Hemolytic anemia following succimer administration in a glucose-6-phosphate dehydrogenase deficient patient.

F Gerr1, H Frumkin, P Hodgins.   

Abstract

Because of its favorable side effects profile, the oral chelating agent dimercaptosuccinic acid is often used for treatment of lead intoxication. We report a case of a 45-year-old black male with glucose-6-phosphate dehydrogenase deficiency and a 17 year history of occupational lead exposure who developed hemolysis during treatment with dimercaptosuccinic acid for symptomatic lead intoxication.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7932916     DOI： 10.3109/15563659409011061

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN： 0731-3810


  4 in total

1.  Lead poisoning: case studies.

Authors:  J N Gordon; A Taylor; P N Bennett
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

Review 2.  Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.

Authors:  Ilan Youngster; Lidia Arcavi; Renata Schechmaster; Yulia Akayzen; Hen Popliski; Janna Shimonov; Svetlana Beig; Matitiahu Berkovitch
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.228

Review 3.  Molecular mechanisms of in vivo metal chelation: implications for clinical treatment of metal intoxications.

Authors:  Ole Andersen; Jan Aaseth
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

4.  A case report of adult lead toxicity following use of Ayurvedic herbal medication.

Authors:  Laura Breeher; Fred Gerr; Laurence Fuortes
Journal:  J Occup Med Toxicol       Date:  2013-10-02       Impact factor: 2.646
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.